NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma Gallery NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma 中国投资项目 NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma 2022-10-01 20:55:09 10月 01日, 2022 | 阅读更多
FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older Gallery FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older 维梧新闻 FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older 2022-08-03 13:49:10 08月 03日, 2022 | 阅读更多
Serán Bioscience Announces Investment by Vivo Capital Gallery Serán Bioscience Announces Investment by Vivo Capital 维梧新闻 Serán Bioscience Announces Investment by Vivo Capital 2022-03-11 16:21:32 03月 11日, 2022 | 阅读更多
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China Gallery VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China 维梧新闻 VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China 2022-03-09 14:40:55 03月 09日, 2022 | 阅读更多
Vivo Capital Appoints New Managing Partners and Partners Gallery Vivo Capital Appoints New Managing Partners and Partners 维梧新闻 Vivo Capital Appoints New Managing Partners and Partners 2022-03-09 14:39:52 03月 09日, 2022 | 阅读更多
Vivo Capital’s Portfolio Company, Preventice was Bought by Boston Scientific for $1.2B Gallery Vivo Capital’s Portfolio Company, Preventice was Bought by Boston Scientific for $1.2B 维梧新闻 Vivo Capital’s Portfolio Company, Preventice was Bought by Boston Scientific for $1.2B 2022-03-09 14:39:09 03月 09日, 2022 | 阅读更多